2X Match My Gift
This National Cancer Survivors Month, your gift is matched to expand treatment options and bring more patients into survivorship through Project Cure CRC.


Once considered a taboo topic, colorectal cancer screening is entering the mainstream. A new national survey finds most Americans are now willing to talk openly about screening and many see encouraging loved ones to get screened as an act of love.
According to the Alliance State of Screening Study, commissioned by the Colorectal Cancer Alliance and conducted by Wakefield Research, 84% of U.S. adults say they would share details about their colorectal cancer screening if it encouraged a friend or family member to get screened. The shift comes at a critical time: Colorectal cancer is now the leading cause of cancer-related death among adults under 50, despite being one of the most preventable cancers. Timely screening can save lives, yet misconceptions and barriers to screening persist.
The Colorectal Cancer Alliance, the nation’s leading nonprofit dedicated to ending the disease, is urging Americans to talk openly with loved ones and take charge of their health during February, National Cancer Prevention Month.
Encouragement Seen as an Act of Love
The survey highlights the emotional power behind screening conversations.
“Talking openly about colorectal cancer isn’t intrusive - it’s an expression of care,” said Michael Sapienza, CEO of the Colorectal Cancer Alliance. “One conversation could help save a loved one’s life.”
Openness Is Growing, but Barriers Remain
While Americans are willing to talk about screening, obstacles still prevent many from getting screened. Sixty percent of adults know that any screening is better than none, yet more than half (54%) say they would be more likely to get screened if the preparation process were easier.
There are multiple screening options, including at-home tests that require no prep, depending on a person’s age, risk factors and preferences. While colonoscopy is the gold standard because it can detect and remove precancerous polyps, at-home options like Cologuard, which detects 92% of colorectal cancers, and a fecal immunochemical test (FIT), which detects 79% of colorectal cancers, are also available.
A Call to Action for February
Encouragingly, 84% of adults who have not already been screened say they plan to get screened within the next year or when they reach the recommended screening age of 45.
During National Cancer Prevention Month, the Colorectal Cancer Alliance encourages all Americans to:
About the Colorectal Cancer Alliance
The Colorectal Cancer Alliance empowers a nation of passionate and determined allies to prevent, treat, and overcome colorectal cancer in their lives and communities. Founded in 1999 and headquartered in Washington, D.C., the Alliance advocates for prevention through initiatives like LEAD FROM BEHIND, magnifies support with BlueHQ, and accelerates research through Project Cure CRC. We are the largest national nonprofit dedicated to colorectal cancer, and we exist to end this disease in our lifetime. For more information, visit colorectalcancer.org.
About the Survey
The Colorectal Cancer Alliance Survey was conducted by Wakefield Research among 1,000 nationally representative U.S. adults ages 18+, between November 24th and December 1st, 2025, using an email invitation and an online survey. The data has been weighted.
Media Contact:
Emily Blasi
eblasi@ccalliance.org
(202) 971-9964

The Colorectal Cancer Alliance is urging Americans to prioritize colorectal cancer screening, as the American Cancer Society (ACS) released updated guidelines today.

As the nation observes Women's Health Month (beginning on Mother's Day) and Clinical Trials Awareness Month, the leading nonprofit Colorectal Cancer Alliance (Alliance) is calling on patients, caregivers, and healthcare providers to confront the urgent and underrecognized public health challenges that may be contributing to the rising death rates.

Asal Sayas, a force for good in public policy and a champion for patients, who worked for both a president and a senator, died Tuesday, April 21, after a defiant six-year path with young-onset colorectal cancer. She was 42 years old.